Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study

Detalles Bibliográficos
Autores principales: Heinz, GH, Priglinger, U, Pabinger, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642593/
http://dx.doi.org/10.1186/cc12289
_version_ 1782268175882125312
author Heinz, GH
Priglinger, U
Pabinger, I
author_facet Heinz, GH
Priglinger, U
Pabinger, I
author_sort Heinz, GH
collection PubMed
description
format Online
Article
Text
id pubmed-3642593
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36425932013-05-13 Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study Heinz, GH Priglinger, U Pabinger, I Crit Care Poster Presentation BioMed Central 2013 2013-03-19 /pmc/articles/PMC3642593/ http://dx.doi.org/10.1186/cc12289 Text en Copyright © 2013 Heinz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Heinz, GH
Priglinger, U
Pabinger, I
Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title_full Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title_fullStr Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title_full_unstemmed Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title_short Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
title_sort anti-xa activities following 5,000 iu and 7,500 iu of s.c. dalteparin in critically ill patients and 5,000 iu in medical patients: a prospective randomized study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642593/
http://dx.doi.org/10.1186/cc12289
work_keys_str_mv AT heinzgh antixaactivitiesfollowing5000iuand7500iuofscdalteparinincriticallyillpatientsand5000iuinmedicalpatientsaprospectiverandomizedstudy
AT priglingeru antixaactivitiesfollowing5000iuand7500iuofscdalteparinincriticallyillpatientsand5000iuinmedicalpatientsaprospectiverandomizedstudy
AT pabingeri antixaactivitiesfollowing5000iuand7500iuofscdalteparinincriticallyillpatientsand5000iuinmedicalpatientsaprospectiverandomizedstudy

Ejemplares similares